Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma by Yufan Huang, Maojin You, Qundan Wu, Ruijia Chen

Connect to this object online.

Estimating the heterogeneous effect of life satisfaction on cognitive functioning among older adults: Evidence of US and UK national surveys by Toshiaki Komura, Richard G. Cowden, Ruijia Chen, Ryan M. Andrews, Koichiro Shiba

Connect to this object online.

Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer by Maojin You, Ruijia Chen, Qingfeng Wu, Wei Zhu, Ying He, Yufan Huang

Connect to this object online.

The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer by Tingting Lu, Yufan Huang, Zhongjie Cai, Wangchun Lin, Xiaoxiao Chen, Ruijia Chen, Yingying Hu

Connect to this object online.

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma by Ying He, Wangchun Lin, Zhongjie Cai, Yufan Huang, Maojin You, Meisheng Lei, Ruijia Chen

Connect to this object online.

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers by Ruijia Chen, Yalan Zhang, Kongying Lin, Defu Huang, MaoJin You, Yanjin Lai, Jinye Wang, Yingying Hu, Na Li, Na Li

Connect to this object online.